Literature DB >> 19465361

Triflusal: an old drug in modern antiplatelet therapy. Review of its action, use, safety and effectiveness.

Hector Anninos1, George Andrikopoulos, Socrates Pastromas, Dimitrios Sakellariou, George Theodorakis, Panos Vardas.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19465361

Source DB:  PubMed          Journal:  Hellenic J Cardiol        ISSN: 1109-9666


× No keyword cloud information.
  4 in total

1.  Bioactivity assessment of natural compounds using machine learning models trained on target similarity between drugs.

Authors:  Vinita Periwal; Stefan Bassler; Sergej Andrejev; Natalia Gabrielli; Kaustubh Raosaheb Patil; Athanasios Typas; Kiran Raosaheb Patil
Journal:  PLoS Comput Biol       Date:  2022-04-25       Impact factor: 4.779

2.  Population pharmacokinetic and pharmacodynamic modeling of transformed binary effect data of triflusal in healthy Korean male volunteers: a randomized, open-label, multiple dose, crossover study.

Authors:  Sung Min Park; Joomi Lee; Sook Jin Seong; Jong Gwang Park; Mi-Ri Gwon; Mi-sun Lim; Hae Won Lee; Young-Ran Yoon; Dong Heon Yang; Kwang-Il Kwon; Seunghoon Han
Journal:  BMC Pharmacol Toxicol       Date:  2014-12-23       Impact factor: 2.483

Review 3.  The Role of Eicosanoids in Alzheimer's Disease.

Authors:  Roger G Biringer
Journal:  Int J Environ Res Public Health       Date:  2019-07-18       Impact factor: 3.390

4.  2-Hydroxy-4-Methylbenzoic Anhydride Inhibits Neuroinflammation in Cellular and Experimental Animal Models of Parkinson's Disease.

Authors:  Soo-Yeol Song; In-Su Kim; Sushruta Koppula; Ju-Young Park; Byung-Wook Kim; Sung-Hwa Yoon; Dong-Kug Choi
Journal:  Int J Mol Sci       Date:  2020-11-02       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.